Suppr超能文献

Eph-和 Ephrin 依赖性机制在肿瘤和干细胞动力学中的作用。

Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.

机构信息

Research Programs Unit, Genome-Scale Biology, Biomedicum Helsinki, University of Helsinki, P.O.B. 63, 00014, Helsinki, Finland.

出版信息

Cell Mol Life Sci. 2014 Oct;71(19):3685-710. doi: 10.1007/s00018-014-1633-0. Epub 2014 May 4.

Abstract

The erythropoietin-producing hepatocellular (Eph) receptors comprise the largest family of receptor tyrosine kinases (RTKs). Initially regarded as axon-guidance and tissue-patterning molecules, Eph receptors have now been attributed with various functions during development, tissue homeostasis, and disease pathogenesis. Their ligands, ephrins, are synthesized as membrane-associated molecules. At least two properties make this signaling system unique: (1) the signal can be simultaneously transduced in the receptor- and the ligand-expressing cell, (2) the signaling outcome through the same molecules can be opposite depending on cellular context. Moreover, shedding of Eph and ephrin ectodomains as well as ligand-dependent and -independent receptor crosstalk with other RTKs, proteases, and adhesion molecules broadens the repertoire of Eph/ephrin functions. These integrated pathways provide plasticity to cell-microenvironment communication in varying tissue contexts. The complex molecular networks and dynamic cellular outcomes connected to the Eph/ephrin signaling in tumor-host communication and stem cell niche are the main focus of this review.

摘要

促红细胞生成素产生肝细胞 (Eph) 受体是受体酪氨酸激酶 (RTK) 家族中最大的成员。最初被认为是轴突导向和组织模式形成分子,Eph 受体现在被归因于发育、组织稳态和疾病发病机制中的各种功能。它们的配体,ephrin,作为膜相关分子合成。这种信号系统具有至少两个独特的特性:(1)信号可以同时在受体和配体表达细胞中传递,(2)通过相同分子的信号转导结果可以根据细胞环境而相反。此外,Eph 和 ephrin 细胞外结构域的脱落以及配体依赖性和非依赖性受体与其他 RTKs、蛋白酶和黏附分子的相互作用拓宽了 Eph/ephrin 功能的范围。这些整合的途径为不同组织环境中的细胞-微环境通讯提供了可塑性。Eph/ephrin 信号在肿瘤-宿主通讯和干细胞龛中的作用涉及复杂的分子网络和动态的细胞结果,这是本综述的主要重点。

相似文献

1
Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.
Cell Mol Life Sci. 2014 Oct;71(19):3685-710. doi: 10.1007/s00018-014-1633-0. Epub 2014 May 4.
2
Eph receptor tyrosine kinases in cancer stem cells.
Cytokine Growth Factor Rev. 2015 Feb;26(1):1-6. doi: 10.1016/j.cytogfr.2014.05.001. Epub 2014 May 17.
3
Eph/ephrin signaling in morphogenesis, neural development and plasticity.
Curr Opin Cell Biol. 2004 Oct;16(5):580-9. doi: 10.1016/j.ceb.2004.07.002.
4
Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!
Cell Adh Migr. 2012 Mar-Apr;6(2):100-1. doi: 10.4161/cam.20890. Epub 2012 Mar 1.
5
The role of ephrins and Eph receptors in cancer.
Cytokine Growth Factor Rev. 2004 Dec;15(6):419-33. doi: 10.1016/j.cytogfr.2004.09.002.
6
Eph receptor and ephrin function in breast, gut, and skin epithelia.
Cell Adh Migr. 2014;8(4):327-38. doi: 10.4161/19336918.2014.970012.
7
Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
Biomed Res Int. 2018 Feb 28;2018:7390104. doi: 10.1155/2018/7390104. eCollection 2018.
8
Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.
Biochim Biophys Acta. 2013 Oct;1834(10):2160-5. doi: 10.1016/j.bbapap.2013.04.020. Epub 2013 Apr 26.
9
The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.
Cancer Metastasis Rev. 2012 Jun;31(1-2):353-73. doi: 10.1007/s10555-012-9352-1.
10
Eph-ephrin bidirectional signaling in physiology and disease.
Cell. 2008 Apr 4;133(1):38-52. doi: 10.1016/j.cell.2008.03.011.

引用本文的文献

1
CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability.
Cancers (Basel). 2025 Jul 1;17(13):2215. doi: 10.3390/cancers17132215.
4
Exploring the complex role of the Eph/Ephrin signaling in oral and maxillofacial cancers.
Front Oncol. 2025 May 12;15:1554751. doi: 10.3389/fonc.2025.1554751. eCollection 2025.
5
A human cell atlas of the pressure-induced hypertrophic heart.
Nat Cardiovasc Res. 2022 Feb;1(2):174-185. doi: 10.1038/s44161-022-00019-7. Epub 2022 Feb 14.
6
Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
7
Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity.
Cell Commun Signal. 2024 May 29;22(1):299. doi: 10.1186/s12964-024-01580-3.
8
Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations.
J Transl Med. 2024 May 15;22(1):459. doi: 10.1186/s12967-024-05294-5.
10
Optogenetic Regulation of EphA1 RTK Activation and Signaling.
bioRxiv. 2024 Feb 7:2024.02.06.579139. doi: 10.1101/2024.02.06.579139.

本文引用的文献

2
Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
PLoS One. 2013 Nov 29;8(11):e81445. doi: 10.1371/journal.pone.0081445. eCollection 2013.
3
Multivalent ligands control stem cell behaviour in vitro and in vivo.
Nat Nanotechnol. 2013 Nov;8(11):831-8. doi: 10.1038/nnano.2013.205. Epub 2013 Oct 20.
4
Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
Neuro Oncol. 2013 Dec;15(12):1710-20. doi: 10.1093/neuonc/not128. Epub 2013 Oct 11.
5
EphA2 bears plasticity to tumor invasion.
Cell Cycle. 2013 Sep 15;12(18):2927-8. doi: 10.4161/cc.26180. Epub 2013 Aug 23.
6
Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14634-9. doi: 10.1073/pnas.1311000110. Epub 2013 Aug 19.
7
Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.
J Thorac Oncol. 2013 Sep;8(9):1203-11. doi: 10.1097/JTO.0b013e31829ceb6a.
9
EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
Stem Cells Dev. 2013 Oct 15;22(20):2751-64. doi: 10.1089/scd.2012.0676. Epub 2013 Jun 29.
10
ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
Oncogene. 2014 Apr 24;33(17):2179-90. doi: 10.1038/onc.2013.180. Epub 2013 May 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验